Newco news Asalyxa raises a seed financing to develop an ARDS therapy Feb. 23, 2021 By Lee Landenberger No Comments Asalyxa Bio Inc. has closed on an oversubscribed seed financing of more than $2 million designed to advance its lead candidate, ASX-100, into the clinic in acute respiratory distress syndrome.Read More
Insmed reports phase I safety and PK data for treprostinil palmitil inhalation powder Feb. 22, 2021 No Comments
Diffusion completes phase Ib study of TSC in hospitalized COVID-19 patients with hypoxemia Feb. 17, 2021 No Comments
NeuroRx reports preliminary phase IIb/III trial data on Zyesami in COVID-19 respiratory failure Feb. 10, 2021 No Comments
In vivo data on IHL-675A supports expansion of indications to include COPD and asthma Feb. 8, 2021 No Comments
RSS
